BINEX Co., Ltd. (KOSDAQ:053030)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,120
+60 (0.37%)
Oct 10, 2025, 3:30 PM KST
0.37%
Market Cap511.47B
Revenue (ttm)153.18B
Net Income (ttm)-18.55B
Shares Out31.85M
EPS (ttm)-587.56
PE Ration/a
Forward PE44.10
Dividendn/a
Ex-Dividend Daten/a
Volume351,754
Average Volume438,209
Open16,250
Previous Close16,060
Day's Range15,740 - 16,330
52-Week Range12,800 - 25,550
Beta0.73
RSI42.26
Earnings DateNov 14, 2025

About BINEX

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company engages in cell line and process development, and analytical method production development. It is also involved in cell cultivation and microbial fermentation modalities process production. In addition, the company offers chemical pharmaceutical products. BINEX Co., Ltd. was founded in 1957 and is headquartered in Busan, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1957
Employees 626
Stock Exchange KOSDAQ
Ticker Symbol 053030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.